TrialBritish journal of cancer2022

Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150.

Ashley M Hopkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.